We examined the expression levels of GLDC in the non-tumor and tumor kidney tissues from RCC patients with poor prognosis and found that expressions of GLDC were dramatically higher in the tumor tissues than those in non-tumor tissues, a finding that provides a novel therapeutic target for the treatment of RCC (Fig. 8F). Here, GLDC is linked to neoplasm.